Title Engineering of perfluorooctylbromide polypyrrole nano-/microcapsules for simultaneous contrast enhanced ultrasound imaging and photothermal treatment of cancer
Authors Zha, Zhengbao
Wang, Jinrui
Zhang, Shuhai
Wang, Shumin
Qu, Enze
Zhang, Youyi
Dai, Zhifei
Affiliation Peking Univ, Coll Engn, Beijing 100871, Peoples R China.
Peking Univ, Hosp 3, Beijing 100871, Peoples R China.
Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.
Keywords Oil-in-water emulsion
Polypyrrole capsules
Perfluorooctylbromide
Ultrasound imaging
Photothermal therapy
COPPER SULFIDE NANOPARTICLES
GOLD NANOCAGES
THERAPY
ABLATION
CELLS
AGENT
DESTRUCTION
MICELLES
DELIVERY
UNIFORM
Issue Date 2014
Publisher biomaterials
Citation BIOMATERIALS.2014,35,(1),287-293.
Abstract A versatile oil-in-water emulsion method has been explored for constructing water-dispersible polypyrrole (PPy) nano-/microcapsules with a soluble PPy complex as multifunctional photothermal agents for tumor ablation. In this work, both PPy nanocapsules (280.4 +/- 79.0 nm) and microcapsules (1.31 +/- 0.45 mu m) with liquid perfluorooctylbromide (PFOB) core could be obtained by simply tuning the process energy for emulsion formation from ultrasonication to homogenization. Owing to the encapsulated liquid PFOB and strong near-infrared (NIR) absorption of PPy shell, the resulted PPy capsules showed great promise in ultrasound imaging guided photothermal ablation of tumor cells without inducing any significant side effect. Thus, it is anticipated that fine-tuning of the other encapsulated drugs or functional materials in PPy capsules would foster avenues for the development of multifunctional platforms for cancer treatments. (C) 2013 Elsevier Ltd. All rights reserved.
URI http://hdl.handle.net/20.500.11897/218923
ISSN 0142-9612
DOI 10.1016/j.biomaterials.2013.09.084
Indexed SCI(E)
EI
Appears in Collections: 工学院
第三医院

Web of Science®


53

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.